The Idiopathic Pulmonary Fibrosis
EIN 820599753Total Given 2018–2024
$500K
4 grants · $71K avg/year
based on 7 yrs of IRS 990-PF records on file
<$100K/yr
micro funder
capacity
$80K
typical mid grants · $25K–$180K
grant size
33%
supporter · 1/3 multi-year
repeat
$2.7M
Assets (2024)
3
Distinct Recipients
Focus Areas
Application Information
Accepts Unsolicited Proposals
No — Preselected Only
Phone
(952) 460-9242
Financial Trends
Giving Over Time
Total Assets Over Time
View financial data as table
| Year | Total Giving | Total Assets | Revenue | Grants |
|---|---|---|---|---|
| 2017 | N/A | $270K | $270K | N/A |
| 2018 | $340K | $734K | $856K | 2 |
| 2019 | N/A | $728K | $75K | N/A |
| 2020 | $30K | $2.5M | $1.8M | 1 |
| 2022 | N/A | $2.7M | $35K | N/A |
| 2023 | N/A | $2.9M | $415K | N/A |
| 2024 | $130K | $2.7M | $178K | 1 |
Grant Size Distribution
Based on 4 grants on record
Minimum
$10K
25th Pctl
$25K
Median
$80K
Average
$125K
75th Pctl
$180K
Maximum
$330K
Geographic Distribution
Officers & Directors
KR
Kristan Rice
7+ yrs
Chief Executive Officer
AB
Anne Christy Ballentine
7+ yrs
Secretary
Leadership
KR
Kristan Rice
7+ yrs
Chief Executive Officer
AB
Anne Christy Ballentine
7+ yrs
Secretary
Leadership
KR
Kristan Rice
7+ yrs
Chief Executive Officer
AB
Anne Christy Ballentine
7+ yrs
Secretary
Leadership
KR
Kristan Rice
7+ yrs
Chief Executive Officer
JC
John Crowe
4 yrs
Chief Financial Officer/Tr
AB
Anne Christy Ballentine
7+ yrs
Secretary
Leadership
KR
Kristan Rice
7+ yrs
Chief Executive Officer
JC
John Crowe
4 yrs
Chief Financial Officer/Tr
AB
Anne Christy Ballentine
7+ yrs
Secretary
Leadership
KR
Kristan Rice
7+ yrs
Chief Executive Officer
JC
John Crowe
4 yrs
Chief Financial Officer/Tr
AB
Anne Christy Ballentine
7+ yrs
Secretary
Leadership
KR
Kristan Rice
7+ yrs
Chief Executive Officer
JC
John Crowe
4 yrs
Chief Financial Officer/Treasurer
Leadership
AB
Anne Christy Ballentine
7+ yrs
Secretary
Leadership
Grants Awarded (4 total)
| Purpose | ||||
|---|---|---|---|---|
| Weill Cornell Medicine | New York, NY | $330,000 | UNRESTRICTED GENERAL OPERATING SUPPORT | 2018 |
| University of California Irvine | Irvine, CA | $130,000 | FOR DR. MICHAEL LEON'S LABORATORY | 2024 |
| Weill Cornell Medicine | New York, NY | $30,000 | UNRESTRICTED GENERAL OPERATING SUPPORT | 2020 |
| Phagebiotics Research Foundation | Olympia, WA | $10,000 | UNRESTRICTED GENERAL OPERATING SUPPORT | 2018 |